| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCNX | Common Stock | Award | $299,999 | +38,610 | +38.8% | $7.77 | 138,138 | 28 Mar 2024 | By Vaccinex (Rochester), L.L.C. | F2 |
| holding | VCNX | Common Stock | 1,580 | 28 Mar 2024 | Direct | ||||||
| holding | VCNX | Common Stock | 1,016 | 28 Mar 2024 | By Jeremy C. Zauderer Trust | F1 | |||||
| holding | VCNX | Common Stock | 1,011 | 28 Mar 2024 | By Jordan M. Zauderer Trust | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCNX | Warrant (Right to Buy) | Award | $299,999 | +38,610 | $7.77 | 38,610 | 28 Mar 2024 | Common Stock | 38,610 | $7.64 | By Vaccinex (Rochester), L.L.C. | F2 | |
| holding | VCNX | Warrant (Right to Buy) | 29,556 | 28 Mar 2024 | Common Stock | 29,556 | $14.00 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
| holding | VCNX | Warrant (Right to Buy) | 9,768 | 28 Mar 2024 | Common Stock | 9,768 | $32.76 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
| holding | VCNX | Warrant (Right to Buy) | 35,714 | 28 Mar 2024 | Common Stock | 35,714 | $14.00 | By Vaccinex (Rochester), L.L.C. | F2 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 12 | 28 Mar 2024 | Common Stock | 12 | $3129.00 | Direct | F3 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 12 | 28 Mar 2024 | Common Stock | 12 | $3129.00 | Direct | F3 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 15 | 28 Mar 2024 | Common Stock | 15 | $1491.00 | Direct | F3 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 135 | 28 Mar 2024 | Common Stock | 135 | $1402.80 | Direct | F3 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 66 | 28 Mar 2024 | Common Stock | 66 | $615.30 | Direct | F4 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 133 | 28 Mar 2024 | Common Stock | 133 | $270.90 | Direct | F5 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 266 | 28 Mar 2024 | Common Stock | 266 | $92.26 | Direct | F6 | |||||
| holding | VCNX | Stock Option (Right to Buy) | 1,877 | 28 Mar 2024 | Common Stock | 1,877 | $9.15 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
| F2 | Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| F3 | Exercisable in full as of the date of this report. |
| F4 | This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice. |
| F5 | This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice. |
| F6 | This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice. |
| F7 | This option vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date, except as otherwise provided in the award notice. |